Aims and scope
The Journal of Ophthalmic Inflammation and Infection is a peer-reviewed open access journal published under the brand SpringerOpen. It presents current clinical and experimental research on a range of ophthalmic inflammation and infection topics.
Coverage includes original studies, review articles, brief reports, case reports, photo essays, and expert commentary on challenging cases. The journal reflects geographical variations in incidence of diseases as well as different treatment modalities worldwide.
This is the official journal of the International Ocular Inflammation Society (IOIS), and the editorial board includes international experts in the field of ophthalmic inflammation and infection.
Why publish your article in Journal of Ophthalmic Inflammation and Infection?
Journal of Ophthalmic Inflammation and Infection's open access policy allows maximum visibility of articles published in the journal as they are available to a wide, global audience.
Speed of publication
Journal of Ophthalmic Inflammation and Infection offers a fast publication schedule whilst maintaining rigorous peer review; all articles must be submitted online, and peer review is managed fully electronically (articles are distributed in PDF form, which is automatically generated from the submitted files). Articles will be published with their final citation after acceptance, in both fully browsable web form, and as a formatted PDF; the article will then be available through Journal of Ophthalmic Inflammation and Infection and SpringerOpen.
Online publication in Journal of Ophthalmic Inflammation and Infection gives you the opportunity to publish large datasets, large numbers of color illustrations and moving pictures, to display data in a form that can be read directly by other software packages so as to allow readers to manipulate the data for themselves, and to create all relevant links (for example, to PubMed, to sequence and other databases, and to other articles).
Promotion and press coverage
Articles published in Journal of Ophthalmic Inflammation and Infection are included in article alerts and regular email updates.
In addition, articles published in Journal of Ophthalmic Inflammation and Infection may be promoted by press releases to the general or scientific press. These activities increase the exposure and number of accesses for articles published in Journal of Ophthalmic Inflammation and Infection.
Authors of articles published in Journal of Ophthalmic Inflammation and Infection retain the copyright of their articles and are free to reproduce and disseminate their work (for further details, see the copyright and license agreement).
For further information about the advantages of publishing in a journal from SpringerOpen, please click here.
All articles published by Journal of Ophthalmic Inflammation and Infection are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers. Further information about open access can be found here.
As authors of articles published in Journal of Ophthalmic Inflammation and Infection you are the copyright holders of your article and have granted to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate your article, according to the SpringerOpen copyright and license agreement.
For those of you who are US government employees or are prevented from being copyright holders for similar reasons, SpringerOpen can accommodate non-standard copyright lines. Please contact us if further information is needed.
Open access publishing is not without costs. Journal of Ophthalmic Inflammation and Infection therefore levies an article-processing charge of £1140/$1780/€1450 for each article accepted for publication. We routinely waive charges for authors from low-income countries. For other countries, article-processing charge waivers or discounts are granted on a case-by-case basis to authors with insufficient funds. Authors can request a waiver or discount during the submission process. For further details, see our article-processing charge page.
A limited number of waivers for article-processing charges are also available at the editors' discretion, and authors wishing to apply for these waivers should contact the editors. Members of the International Ocular Inflammation Society (IOIS) will receive a 50% discount on the article-processing charge for articles they publish in Journal of Ophthalmic Inflammation and Infection. Please request the discount code by contacting the Society.
For non-members of the Society, some or all of the publication cost may be covered if the corresponding author's institution participates in our open access membership program (more details available on the membership page).
Springer Open provides a free open access funding support service to help authors discover and apply for article processing charge funding. Visit our OA funding and policy support page to view our list of research funders and institutions that provide funding for APCs, and to learn more about our email support service.
All articles published in Journal of Ophthalmic Inflammation and Infection are included in:
- Emerging Sources Citation Index
- PubMed Central
- Summon by ProQuest
The full text of all articles is deposited in digital archives around the world to guarantee long-term digital preservation. You can also access all articles published by SpringerOpen on SpringerLink.
We are working closely with relevant indexing services including Web of Science (Thomson Reuters) to ensure that articles published in Journal of Ophthalmic Inflammation and Infection will be available in their databases when appropriate.
Journal of Ophthalmic Inflammation and Infection operates a single-blind peer-review system, where the reviewers are aware of the names and affiliations of the authors, but the reviewer reports provided to authors are anonymous.
The benefit of single-blind peer review is that it is the traditional model of peer review that many reviewers are comfortable with, and it facilitates a dispassionate critique of a manuscript.
Publication of research articles by Journal of Ophthalmic Inflammation and Infection is dependent primarily on their scientific validity and coherence as judged by our external expert editors and/or peer reviewers, who will also assess whether the writing is comprehensible and whether the work represents a useful contribution to the field. Submitted manuscripts will generally be reviewed by two to three experts who will be asked to evaluate whether the manuscript is scientifically sound and coherent, whether it duplicates already published work, and whether or not the manuscript is sufficiently clear for publication. Reviewers will also be asked to indicate how interesting and significant the research is. The Editors will reach a decision based on these reports and, where necessary, they will consult with members of the Editorial Board.
All manuscripts submitted to Journal of Ophthalmic Inflammation and Infection should adhere to SpringerOpen's editorial policies.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Citing articles in Journal of Ophthalmic Inflammation and Infection
Articles in Journal of Ophthalmic Inflammation and Infection should be cited in the same way as articles in a traditional journal. Because articles are not printed, they do not have page numbers; instead, they are given a unique article number.
Article citations follow this format:
Authors: Title. J OPHTH INFLAMM INFECT [year], [volume number]:[article number].
e.g. Roberts LD, Hassall DG, Winegar DA, Haselden JN, Nicholls AW, Griffin JL: Increased hepatic oxidative metabolism distinguishes the action of Peroxisome Proliferator-Activated Receptor delta from Peroxisome Proliferator-Activated Receptor gamma in the Ob/Ob mouse. J OPHTH INFLAMM INFECT 2009, 1:115.
refers to article 115 from Volume 1 of the journal.
Appeals and complaints
If you wish to appeal a rejection or make a complaint you should, in the first instance, contact the Editor who will provide details of the journal's complaints procedure.